LEIDY CARABALLO GALVA to Liver Neoplasms
This is a "connection" page, showing publications LEIDY CARABALLO GALVA has written about Liver Neoplasms.
Connection Strength
0.664
-
Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology. 2022 08; 76(2):330-344.
Score: 0.354
-
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma. J Genet Genomics. 2020 01 20; 47(1):1-15.
Score: 0.310